
|Videos|January 13, 2015
How New Regulatory Requirements Have Affected Controlled Dangerous Substance Dispensing
Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how new regulatory requirements have affected controlled dangerous substance dispensing.
Advertisement
Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how new regulatory requirements have affected controlled dangerous substance dispensing.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
3
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
4
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
5

















































































































































































































